Published in J Thromb Haemost on February 06, 2010
Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis (Armour) | NCT01324037
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50
Upper extremity deep vein thrombosis. Int J Crit Illn Inj Sci (2012) 0.87
Emergency Physician Performed Ultrasound for DVT Evaluation. Thrombosis (2011) 0.81
Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation. Ther Clin Risk Manag (2015) 0.79
Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations. Curr Oncol (2015) 0.78
Extrinsic subclavian vein compression after osteosynthesis of a midshaft clavicular fracture in an athlete. Case Rep Orthop (2015) 0.75
The Incidence of Peripheral Catheter-Related Thrombosis in Surgical Patients. Thrombosis (2016) 0.75
Emergency department diagnosis of upper extremity deep venous thrombosis using bedside ultrasonography. Crit Ultrasound J (2012) 0.75
SCREENING FOR REFERRAL BY A SPORTS PHYSICAL THERAPIST REVEALS AN EFFORT THROMBOSIS IN A COLLEGIATE PITCHER: A CASE REPORT. Int J Sports Phys Ther (2016) 0.75
Catheter-related thrombosis: A practical approach. J Intensive Care Soc (2015) 0.75
Vascular TOS-Creating a Protocol and Sticking to It. Diagnostics (Basel) (2017) 0.75
Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ (1998) 6.07
Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med (1992) 5.48
Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess (2004) 5.31
Travel and risk of venous thrombosis. Lancet (2000) 5.23
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet (1995) 5.10
Once versus thrice daily gentamicin in patients with serious infections. Lancet (1993) 4.92
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet (1992) 4.15
Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis. Ann Intern Med (1992) 3.74
On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res (2003) 3.71
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost (2007) 3.66
The quality of diagnostic accuracy studies since the STARD statement: has it improved? Neurology (2006) 3.63
Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med (1996) 3.42
Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med (1997) 3.26
Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med (1990) 2.82
Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess (2007) 2.79
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet (1999) 2.77
Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med (1989) 2.73
[Risk factors for structural chromosomal abnormality in > or = 2 miscarriages, as an instrument for selective karyotyping]. Ned Tijdschr Geneeskd (2007) 2.71
Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet (2000) 2.49
A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med (1993) 2.39
Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol (2000) 2.35
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood (1990) 2.33
Activation of coagulation system during air travel: a crossover study. Lancet (2006) 2.32
Mortality in hereditary antithrombin-III deficiency--1830 to 1989. Lancet (1991) 2.31
Meta-analysis: the final answer, or even more confusion? Lancet (1996) 2.24
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost (2013) 2.24
Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax (2008) 2.24
Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet (1997) 2.20
Prevention of deep vein thrombosis after hip replacement--comparison between two low-molecular heparins, tinzaparin and enoxaparin. Thromb Haemost (1999) 2.18
Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis. Lancet (1994) 2.18
High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost (2000) 2.15
Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences. J Thromb Haemost (2006) 2.06
[Limited predictive value of diagnostic tests for outcomes following pelvic floor physiotherapy in patients with faecal incontinence]. Ned Tijdschr Geneeskd (2008) 2.02
Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med (1999) 2.00
Deep-vein thrombosis. Lancet (1999) 1.98
Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting. J Thromb Haemost (2013) 1.97
Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curves. Med Decis Making (1997) 1.96
Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism: is a more extensive assessment of compressibility useful? Thromb Haemost (2000) 1.95
Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med (1999) 1.95
Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol (2004) 1.92
Transgenerational effects of prenatal exposure to the 1944-45 Dutch famine. BJOG (2013) 1.89
Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples. Hum Reprod (2006) 1.86
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med (1999) 1.81
Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev (2007) 1.81
Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med (1990) 1.76
Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism. ANTELOPE-Study Group. Thromb Haemost (2000) 1.73
Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet (1992) 1.73
A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Ann Intern Med (2001) 1.72
Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis. Hum Reprod Update (2010) 1.72
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost (2005) 1.70
Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost (2006) 1.69
Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr (2001) 1.68
Decision analysis for cancer screening in idiopathic venous thromboembolism. J Thromb Haemost (2005) 1.65
Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ (1991) 1.65
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med (1994) 1.64
Thyroid diseases and cerebrovascular disease. Stroke (2005) 1.63
Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo. Am Heart J (2001) 1.62
Reliable rapid blood test for the exclusion of venous thromboembolism in symptomatic outpatients. Thromb Haemost (1996) 1.61
The value of lung scintigraphy in the diagnosis of pulmonary embolism. Eur J Nucl Med (1993) 1.61
High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol (1999) 1.60
Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Thromb Haemost (1999) 1.60
Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Intern Med (1997) 1.57
Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost (1997) 1.56
Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med (1997) 1.54
Family history and inherited thrombophilia. J Thromb Haemost (2006) 1.52
Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery. J Thromb Haemost (2009) 1.52
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest (1994) 1.50
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. Thromb Haemost (2000) 1.49
Use of methodological search filters to identify diagnostic accuracy studies can lead to the omission of relevant studies. J Clin Epidemiol (2006) 1.49
Absorbable collagen membranes for periodontal regeneration: a systematic review. J Dent Res (2013) 1.48
Improving the existing diagnostic strategy by accounting for characteristics of the women in the diagnostic work up for postmenopausal bleeding. BJOG (2007) 1.48
An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod (2004) 1.47
Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis. J Thromb Haemost (2006) 1.46
The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis. Thromb Haemost (2001) 1.45
Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey. Neth J Med (2006) 1.45
Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations. J Thromb Haemost (2007) 1.44
Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia (2006) 1.43
Yield of screening for new aneurysms after treatment for subarachnoid hemorrhage. Neurology (2004) 1.43
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thromb Haemost (2000) 1.43
Active implementation of a consensus strategy improves diagnosis and management in suspected pulmonary embolism. QJM (2000) 1.42
Venous thromboembolism--prophylactic and therapeutic practice guideline. S Afr Med J (2009) 1.42
Survey of the management of deep vein thrombosis in general practice in the Netherlands. Neth J Med (2000) 1.39
[Costs of diagnosis and treatment for pulmonary embolism lower due to application of consensus strategy]. Ned Tijdschr Geneeskd (1996) 1.39
Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism. J Thromb Haemost (2005) 1.38
[The diagnosis of pulmonary embolism: the best strategies according to the results of a large Dutch multicentre study]. Ned Tijdschr Geneeskd (2005) 1.38
[Diagnostic management in suspicion of pulmonary embolism: results of a survey among Dutch internists and pulmonologists]. Ned Tijdschr Geneeskd (1992) 1.38
[Doubts as to the cardiovascular safety of rosiglitazone]. Ned Tijdschr Geneeskd (2007) 1.38
Low-molecular-weight heparins in the treatment of venous thromboembolism. Ann Intern Med (1998) 1.38
Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism. Neth J Med (2011) 1.38
Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study. Clin Microbiol Infect (2007) 1.38
[Physical examination--the significance of Homan's sign]. Ned Tijdschr Geneeskd (1999) 1.38
[Postmenopausal estrogen substitution and the risk of atherosclerotic heart and vascular diseases]. Ned Tijdschr Geneeskd (1992) 1.37
Cell-derived microvesicles and cancer. Neth J Med (2009) 1.33